Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program

Journal of Nephropathology

Volumn 3, Issue 2, 2014, Pages 69-79

  Khan, Hamid ^a   Mubarak, Muhammed ^a   Aziz, Tahir ^a   Ahmed, Ejaz ^a   Akhter, Syed Fazal ^a   Kazi, Javed ^a   Naqvi, Syed A A ^a   Rizvi, Syed A H ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

Delayed graft failure; Graft biopsy; Live related; Rejectio; Transplant outcome

Indexed keywords

EID: 84902132265     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.12860/jnp.2014.15     Document Type: Article

References (38)

1. Pascual M, Theruvath T, Kawai T, Tolkaff-Rubin N, Cusimi AB. Strategies to improve long term out come after renal transplantation. New Engl J Med 2002; 346 (8):580-90.
2. Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and five years post-transplantation: 1996 UNOS Update. Clin Transpl 1996:343-60.
3. Cecka JM. The UNOS Scientific Renal Transplant Registry. Clin Transpl 1998:1-16.
4. Cecka JM. The UNOS renal transplant registry. Clin Transpl 2001:1-18
5. Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349(24):2326-33.
6. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10(1):167-81.
7. Cornell LD, Colvin RB. Chronic allograft nephropathy. Curr Opin Nephrol Hypertens 2005; 14(3):229-34.
8. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342(9):605-12.
9. Campistol JM, Boletis IN, Dantal J, de Fijter JW, Hertig A, Neumayer HH, et al. Chronic allograft nephropathy--a clinical syndrome: early detection and the potential role of proliferation signal inhibitors. Clin Transplant 2009;23(6):769-77.
10. Swanson SJ, Hypolite IO, Agodoa LY, Batty DS Jr, Hshieh PB, Cruess D, et al. Effect of donor factors on early graft survival in adult cadaveric renal transplantation. Am J Transplant 2002; 2(1): 68-75.
11. Humar A, Hassoun A, Kandaswamy R, Payne WD, Sutherland DE, Matas AJ. Immunologic factors: the majo;r risk for decreased long-term renal allograft survival. Transplantation 1999; 68(12):1842-6.
12. Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 2002; 74(4): 576-8.
13. Kasiske BL, Andany MA, Danielson B. A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure. Am J Kidney Dis 2002; 39(4):762-8.
14. Isoniemi H, Nurminen M, Tikkanen MJ, Von Willebrand E, Krogerus L, Ahonen J, et al. Risk factors predicting chronic rejection of renal allografts. Transplantation 1994; 57(1):68-72.
15. Stoves J, Newstead CG. Variability of cyclosporine exposure and its relevance to chronic allograft nephropathy: a case-control study. Transplantation 2002; 74(12): 1794-7.
16. Massy ZA, Guijarro C, Kasiske BL. Clinical predictors of chronic renal allograft rejection. Kidney Int 1995; 52: S85-S88.
17. Kazi J, Mubarak M. Biopsy findings in renal allograft dysfunction in a live related renal transplant program. J Transplant Tech Res 2012; 2:108.
18. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55(2):713-23.
19. Solez K, Colvin RB, Racusen LC, Siss B, Halloran PF, Birk PE, et al. Banff’05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007;7(3):518-26.
20. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff’ 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8(4):753-60.
21. McKenna RM, Takemoto SK, Terasaki PI. Anti- HLA antibodies after solid organ transplantation. Transplantation 2000;69(3):319-26.
22. Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003;75(7):1034-40.
23. Lee PC, Terasaki PI, Takemoto SK, Lee PH, Hung CJ, Chen YL, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002;74(8):1192-4.
24. Piazza A, Poggi E, Borrelli L, Servetti S, Monaco PI, Buonomo O, et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation 2001;71(8):1106-12.
25. Opelz G. Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. Transplantation 1997;64(10):1473-5.
26. Matas AJ, Humar A, Gillingham KJ, Payne WD, Gruessner RW, Kandaswamy R, et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int 2002;62(2):704-14.
27. Kuypers DR, Chapman JR, O’Connell PJ, Allen RD, Nankivell BJ. Predictors of renal transplant histology at three months. Transplantation 1999;67(9):1222-30.
28. Marcen R, Pascual J, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, et al. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss? Transplantation 2001;72(1):57-62.
29. Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant Int 2005;18(1):22-8.
30. Mueller A, Schnuella P, Waldhere R, Vander Wounde FJ. Impact of the Banff’ 97 classification for histological diagnosis of rejection on clinical outcome and renal function Parameters after kidney transplantation. Transplantation 2000;69(6)1123-7.
31. van Saase JL, van der Woude FJ, Thorogood J, Hollander AA, van Es LA, Weening JJ, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995,59(9):1280-5.
32. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003;3(6):665-73.
33. Panigrahi A, Deka R, Bhowmik D, Tiwari SC, Mehra NK. Immunological monitoring of post-transplant allograft sensitization following living related donor renal transplant. Transplant Proc 2004;36(5):1336-9.
34. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000;69(11):2405-2409.
35. Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, et al. Sirolimus-Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years. Am J Transplant 2004;4(6):953-961.
36. Müller V, Becker G, Delfs M, Albrecht KH, Philipp T, Heemann U. Do urinary tract infections trigger chronic kidney transplant rejection in man? J Urol 1998;159(6):1826-9.
37. Iqbal T, Naqvi R, Akhter SF. Frequency of urinary tract infection in renal transplant recipients and effect on graft function. J Pak Med Assoc 2010;60(10):826-9.
38. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002;62(1):311-318.